← Eichor
Condition: Oncolytic Virus Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Oncolytic Virus

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors
Phase 1 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT07656116Trial of THEO-260 (Administered Via Intraperitoneal Route) in Ovarian Cancer Patients
Phase 1 · 1 location(s) · Theolytics Limited · NCT07211659Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Beva
Phase 3 · 32 location(s) · Genelux Corporation · NCT05281471OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer
Phase 1 · 1 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT05698459A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors
Phase 1 · 10 location(s) · Johnson & Johnson Enterprise Innovation Inc. · NCT06311578OH2 Oncolytic Viral Therapy in Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT03866525Safety and Efficacy of NRG-103 Injection in the Treatment of Recurrent Glioblastoma Patients
EARLY_Phase 1 · 1 location(s) · Zhongnan Hospital · NCT06757153Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors
Phase 1 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT07001592OH2 Injection in Combination With HX008 for Melanoma.
Phase 1/Phase 2 · 1 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT04616443OH2 Injection in Melanoma
Phase 3 · 30 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT05868707Clinical Study on the Safety and Efficacy of TS-2021 in the Treatment of Recurrent Malignant Glioma
Phase 1 · 1 location(s) · Beijing Neurosurgical Institute · NCT06585527A Phase I Clinical Study of Intratumoral Injection GC001 in Patient With Recurrent or Progressive Gliomas
Phase 1 · 1 location(s) · GONGCHU Biotechnology Co., Ltd · NCT06660056OH2 Injection in Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT04386967H101 Plus TACE for r/m HNSCC
Phase 2 · 1 location(s) · West China Hospital · NCT07398664A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors
Phase 1 · 1 location(s) · GONGCHU Biotechnology Co., Ltd · NCT06508307MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors
Phase 1 · 2 location(s) · Memgen, Inc. · NCT05076760Oncolytic Virotherapy to Enhance PReoperative IMmunotherapy Efficacy in Patients With Proficient Mismatch Repair (pMMR)
Phase 1 · 1 location(s) · Henry Smith · NCT07687875SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Dif
Phase 1 · 1 location(s) · Peter Hosein, MD · NCT06889493Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
Phase 1 · 1 location(s) · Capital Medical University · NCT05717699GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid Tumors
Phase 1/Phase 2 · 4 location(s) · GeneMedicine Co., Ltd. · NCT06265025A Clinical Trial Aimed at Assessing the Efficacy and Safety of VT-101 for the Treatment of Non-muscle Invasive Bladder C
Phase 1 · 1 location(s) · The Affiliated Hospital of Xuzhou Medical University · NCT06632964A Study to Evaluate Combination Therapy of Oncolytic Vaccinia Virus (hV01) and PD-1 Inhibitor in Advanced Solid Tumors.
NA · 1 location(s) · Hangzhou Converd Co., Ltd. · NCT07185243Intratumoral DNX-2401 for High Grade Pediatric Brain Tumors
Phase 2 · 2 location(s) · Clinica Universidad de Navarra, Universidad de Navarra · NCT07424092OH2 Oncolytic Viral Therapy in Central Nervous System Tumors
Phase 1/Phase 2 · 1 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT05235074A Study of Recombinant Oncolytic Virus M1(VRT106) in Patients With Solid Tumors
Phase 1 · 3 location(s) · Guangzhou Virotech Pharmaceutical Co., Ltd. · NCT06368921A Clinical Study of GO306 in Patients With Advanced Solid Tumors
Phase 1 · 6 location(s) · GeneSail Biotech (Shanghai) Co., Ltd. · NCT07128914A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Tr
Phase 1 · 5 location(s) · Abalos Therapeutics GmbH · NCT07231458OH2 Oncolytic Viral Therapy in Non-Muscle-Invasive Bladder Cancer
Phase 1/Phase 2 · 1 location(s) · Binhui Biopharmaceutical Co., Ltd. · NCT05232136Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Pancreatic Cancer
Phase 2 · 1 location(s) · Hangzhou Converd Co., Ltd. · NCT07006077PIN in Combination With Anti-PD1 in Previously Treated Solid Tumor
Phase 1 · 1 location(s) · Chinese PLA General Hospital · NCT06883149
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.